Sanofi to cut US price of its most-prescribed insulin by 78% ...Middle East

Sanofi SA said on Thursday it will cut U.S. list prices for its most-prescribed insulin product, Lantus, by 78% starting next year after similar moves by rivals Novo Nordisk and Eli Lilly and Co . The French drugmaker will also extend its $35 out-of-pocket pricing program to all patients with commercial insurance using Lantus.

Hence then, the article about sanofi to cut us price of its most prescribed insulin by 78 was published today ( Friday 17/03/2023 - 01:48 AM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sanofi to cut US price of its most-prescribed insulin by 78% )

Also on site :

• Italian Ambassador Returns to Switzerland Amid Fire Tragedy Protest
• Local vs. External: Ladakh's Tourism Stakeholders Unite for Ecological Integrity
• Why Markwayne Mullin must prioritize the trade engine of Homeland Security